# Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome

> **NCT03009838** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 150 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Letrozole
- **PROCEDURE:** ovarian drilling

## Key facts

- **NCT ID:** NCT03009838
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-02
- **Primary completion:** 2022-12
- **Final completion:** 2023-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009838, "Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03009838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*